Seagen Inc
Change company Symbol lookup
Select an option...
SGEN Seagen Inc
LIN Linde PLC
ENLV Enlivex Therapeutics Ltd
WSTG Wayside Technology Group Inc
ATRO Astronics Corp
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in the development and sale of pharmaceutical products on its own, behalf or in collaboration with others. The Company is commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, and TUKYSA, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. The Company also develops a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs. Its programs, including ADCETRIS and PADCEV, are based on its antibody-drug conjugate (ADC), technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The Company's approved medicines include ADCETRIS, PADCEV and TUKYSA.

Closing Price
$178.47
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
2,616,125
0
  • Prev Close
    178.47
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.6M
  • Last (time)
    4:00p ET 06/28/22
  • Last (size)
    2
  • 52-Wk Range
    105.43 - 192.79
    LowHigh
  • (11/08/21 - 05/09/22)
    7.43%
  • 41.6%
  • Market Cap
    32.9B
  • Shares Outstanding
    184.1M
  • -3.77
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 92.13
  • (% of float 06/15/22)
    1.82

Latest News

June 28, 2022
12:32 pm ET
Zacks
June 17, 2022
11:03 am ET
MarketWatch
June 06, 2022
11:00 am ET
BusinessWire
11:00 am ET
BusinessWire
June 03, 2022
3:12 pm ET
BusinessWire
May 26, 2022
5:25 pm ET
BusinessWire
5:00 pm ET
BusinessWire
May 23, 2022
8:00 am ET
BusinessWire
May 16, 2022
9:59 am ET
MarketWatch
6:00 am ET
BusinessWire
May 09, 2022
6:00 am ET
BusinessWire
April 28, 2022
4:02 pm ET
BusinessWire
8:00 am ET
BusinessWire
April 20, 2022
9:00 am ET
BusinessWire
April 13, 2022
11:45 am ET
BusinessWire
April 08, 2022
3:23 pm ET
BusinessWire
1:19 pm ET
BusinessWire
April 07, 2022
8:00 am ET
BusinessWire
February 10, 2022
2:48 pm ET
MarketWatch
February 01, 2022
8:17 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.